Zobrazeno 1 - 8
of 8
pro vyhledávání: '"ELIAS B. RASHU"'
Autor:
Josephine Grandt, Anne‐Sofie H. Jensen, Mikkel P. Werge, Elias B. Rashu, Andreas Møller, Anders E. Junker, Lise Hobolth, Christian Mortensen, Christian D. Johansen, Mogens Vyberg, Reza Rafiolsadat Serizawa, Søren Møller, Lise Lotte Gluud, Nicolai J. Wewer Albrechtsen
Publikováno v:
Physiological Reports, Vol 11, Iss 8, Pp n/a-n/a (2023)
Abstract Fatty liver disease has mainly been characterized under fasting conditions. However, as the liver is essential for postprandial homeostasis, identifying postprandial disturbances may be important. Here, we investigated postprandial changes i
Externí odkaz:
https://doaj.org/article/5b92858c4b1641adbc65716474f5fd74
Autor:
Sasha A.S. Kjeldsen, Michael M. Richter, Nicole J. Jensen, Malin S.D. Nilsson, Niklas Heinz, Janus D. Nybing, Frederik H. Linden, Erik Høgh-Schmidt, Mikael P. Boesen, Sten Madsbad, Hendrik Vilstrup, Frank Vinholt Schiødt, Andreas Møller, Kirsten Nørgaard, Signe Schmidt, Elias B. Rashu, Lise L. Gluud, Steen B. Haugaard, Jens J. Holst, Jørgen Rungby, Nicolai J. Wewer Albrechtsen
Publikováno v:
Kjeldsen, S A S, Richter, M M, Jensen, N J, Nilsson, M S D, Heinz, N, Nybing, J D, Linden, F H, Høgh-Schmidt, E, Boesen, M P, Madsbad, S, Vilstrup, H, Schiødt, F V, Møller, A, Nørgaard, K, Schmidt, S, Rashu, E B, Gluud, L L, Haugaard, S B, Holst, J J, Rungby, J & Wewer Albrechtsen, N J 2023, ' Development of a glucagon sensitivity test in humans : Pilot data and the GLUSENTIC study protocol ', Peptides, vol. 161, 170938 . https://doi.org/10.1016/j.peptides.2022.170938
A physiological feedback system exists between hepatocytes and the alpha cells, termed the liver-alpha cell axis and refers to the relationship between amino acid-stimulated glucagon secretion and glucagon-stimulated amino acid catabolism. Several re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa7d70f6ae68bbda8b6c4b8ff7a9ceb4
https://pure.au.dk/portal/da/publications/development-of-a-glucagon-sensitivity-test-in-humans(747b7db4-ffca-402a-9e23-693d4956b3dc).html
https://pure.au.dk/portal/da/publications/development-of-a-glucagon-sensitivity-test-in-humans(747b7db4-ffca-402a-9e23-693d4956b3dc).html
Autor:
Josephine Grandt, Christian D. Johansen, Anne-Sofie H. Jensen, Mikkel P. Werge, Elias B. Rashu, Andreas Møller, Anders E. Junker, Lise Hobolth, Christian Mortensen, Mogens Vyberg, Reza Rafiolsadat Serizawa, Søren Møller, Lise Lotte Gluud, Nicolai Jacob Wewer Albrechtsen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3daa9f8ac83a9eff98edc7f48e3551a9
https://doi.org/10.2139/ssrn.4427001
https://doi.org/10.2139/ssrn.4427001
Autor:
Sasha A. S. Kjeldsen, Michael M. Richter, Nicole J. Jensen, Malin S. D. Nilsson, Niklas Heinz, Janus D. Nybing, Frederik H. Linden, Erik Høgh-Schmidt, Mikael P. Boesen, Sten Madsbad, Hendrik Vilstrup, Frank Vinholt Schiødt, Andreas Møller, Kirsten Nørgaard, Signe Schmidt, Elias B. Rashu, Lise L. Gluud, Steen B. Haugaard, Jens J. Holst, Jørgen Rungby, Nicolai J. Wewer Albrechtsen
IntroductionA physiological feedback system exists between hepatocytes and the alpha cells termed the liver-alpha cell axis and signifies the role between amino acid-stimulated glucagon secretion and glucagon-stimulated amino acid catabolism. Several
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdf4f878d57d2fc131a301c3576b5ba3
https://doi.org/10.1101/2022.11.05.22281981
https://doi.org/10.1101/2022.11.05.22281981
Autor:
JOSEPHINE GRANDT, ANNE-SOFIE H. JENSEN, MIKKEL P. WERGE, ELIAS B. RASHU, ANDERS JUNKER, LISE HOBOLTH, CHRISTIAN MORTENSEN, MOGENS VYBERG, REZA SERIZAWA, SØREN MØLLER, LISE GLUUD, NICOLAI J. WEWER ALBRECHTSEN
Publikováno v:
Diabetes. 71
Metabolic dysfunction in patients with metabolic fatty liver disease (MAFLD) may increase the risk for diabetes development. The liver is essential for the postprandial control of our metabolism and hormonal response, yet most studies focus on fastin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a0b6ba502e4374f10bcc3b159eef421
https://doi.org/10.2337/db22-273-or
https://doi.org/10.2337/db22-273-or
Autor:
ANNE-SOFIE H. JENSEN, HENRIETTE YTTING, JOSEPHINE GRANDT, ANDREAS MØLLER, MIKKEL P. WERGE, ELIAS B. RASHU, LIV E. HETLAND, ANDERS JUNKER, LISE HOBOLTH, CHRISTIAN MORTENSEN, FLEMMING TOFTENG, SØREN MØLLER, MOGENS VYBERG, REZA SERIZAWA, LISE GLUUD, NICOLAI J. WEWER ALBRECHTSEN
Publikováno v:
Diabetes. 71
Gluco-regulatory disturbances such as hepatic insulin resistance, hyperinsulinemia and prediabetes are commonly present in patients with nonalcoholic fatty liver disease (NAFLD) and those individuals may over time develop full-blown type 2 diabetes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe26374f987fb03c967e0e4af24acbb7
https://doi.org/10.2337/db22-1338-p
https://doi.org/10.2337/db22-1338-p
Autor:
SASHA KJELDSEN, NICOLE J. JENSEN, MALIN NILSSON, NIKLAS HEINZ, JANUS D. NYBING, FREDERIK H. LINDEN, ERIK HØGH-SCHMIDT, MIKAEL P. BOESEN, STEN MADSBAD, HENDRIK VILSTRUP, FRANK V. SCHIØDT, ANDREAS MØLLER, ELIAS B. RASHU, LISE GLUUD, STEEN B. HAUGAARD, JENS J. HOLST, JOERGEN RUNGBY, NICOLAI J. WEWER ALBRECHTSEN
Publikováno v:
Diabetes. 71
Glucagon is essential for glucose control and increased levels of glucagon (hyperglucagonemia) observed in patients with type 2 diabetes contribute to their hyperglycemia. Recently, hyperglucagonemia has also been found in individuals with non-alcoho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74179eaf917291aa7c41eac387f8b4fb
https://doi.org/10.2337/db22-1343-p
https://doi.org/10.2337/db22-1343-p
Autor:
Nicolai J. Wewer Albrechtsen, Andreas Møller, Christoffer Martinussen, Lise L. Gluud, Elias B. Rashu, Michael M. Richter, Peter Plomgaard, Jens P. Goetze, Sasha Kjeldsen, Lasse Holst Hansen, Finn Gustafsson, Carolyn F. Deacon, Jens J. Holst, Sten Madsbad, Kirstine N. Bojsen‐Møller
Publikováno v:
Wewer Albrechtsen, N J, Møller, A, Martinussen, C, Gluud, L L, Rashu, E B, Richter, M M, Plomgaard, P, Goetze, J P, Kjeldsen, S, Hansen, L H, Gustafsson, F, Deacon, C F, Holst, J J, Madsbad, S & Bojsen-Møller, K N 2022, ' Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes ', Diabetes, Obesity and Metabolism, vol. 24, no. 10, pp. 2017-2026 . https://doi.org/10.1111/dom.14789
Sacubitril/valsartan is a neprilysin-inhibitor/angiotensin II receptor blocker used for the treatment of heart failure. Recently, a post-hoc analysis of a 3-year randomized controlled trial showed improved glycaemic control with sacubitril/valsartan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aba6846d3a03bd775f4f6e599570ac24
https://pubmed.ncbi.nlm.nih.gov/35676803
https://pubmed.ncbi.nlm.nih.gov/35676803